Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1959 1
1967 1
1968 1
1969 2
1970 1
1971 1
1972 2
1973 2
1974 1
1975 1
1976 2
1978 3
1983 1
1984 2
1986 2
1987 3
1988 2
1989 1
1990 1
1991 1
1992 5
1993 5
1994 5
1995 3
1996 6
1997 4
1998 4
1999 7
2000 3
2001 5
2002 5
2003 4
2004 8
2005 10
2006 12
2007 11
2008 16
2009 17
2010 17
2011 28
2012 29
2013 25
2014 33
2015 45
2016 31
2017 36
2018 53
2019 47
2020 44
2021 47
2022 37
2023 47
2024 38
2025 28
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

664 results

Results by year

Filters applied: . Clear all
Page 1
Gene therapy supports long-term reconstitution of patient hematopoietic stem cells in deficiency of adenosine deaminase 2.
Rigamonti C, Bulté D, Barzaghi F, Mesa-Nuñez C, Basso-Ricci L, Pettinato E, Visconti C, Degl'Innocenti S, Gazzo F, Benedicenti F, Arévalo S, Quaranta P, Sanvito F, Caorsi R, Schena F, Lupia M, Federici S, Insalaco A, De Benedetti F, Scala S, Miano M, Conti F, Cicalese MP, Montini E, Gattorno M, Dufour C, Aiuti A, Mortellaro A. Rigamonti C, et al. Among authors: dufour c. Mol Ther Methods Clin Dev. 2025 Oct 30;33(4):101624. doi: 10.1016/j.omtm.2025.101624. eCollection 2025 Dec 11. Mol Ther Methods Clin Dev. 2025. PMID: 41321395 Free PMC article.
Uncommon causal variants of the ADA2 gene in patients with reduced enzyme activity and non-confirmatory genetic testing.
Grossi A, Cafaro A, Rusmini M, Rosamilia F, Malacarne M, Testa B, Lupia M, Giarratana MC, Miano M, Barzaghi F, Caorsi R, Conti C, Vozzi D, Uva P, Cangemi G, Dufour C, Gattorno M, Ceccherini I. Grossi A, et al. Among authors: dufour c. J Allergy Clin Immunol Pract. 2025 Nov 27:S2213-2198(25)01131-6. doi: 10.1016/j.jaip.2025.11.026. Online ahead of print. J Allergy Clin Immunol Pract. 2025. PMID: 41317964 Free article. No abstract available.
Pirates of the Caribbean (and Elsewhere): Three-Legged Lizards and the Study of Evolutionary Adaptation.
Stroud JT, Kolbe JJ, Doshna B, Anderson CV, French SS, Miles DB, Zani PA, Suh JJ, Passos DC, Roberts TJ, Whiting MJ, Cusick K, Aja M, Appleton M, Arnashus A, Arnold DS, Bastiaans E, Barnett K, Boronow KE, Brisson JA, Calder D, Clay S, Clobert J, Connior MB, Cooper TL, Castañeda MDR, Dufour CMS, Gamble T, Geneva AJ, Gray LN, Griffin K, Hall JM, Herrmann NC, Hillen B, Johnson LE, Kamath A, Langkilde T, Langner C, Lapiedra O, Leal M, Maayan I, Massot M, Miller AH, Muñoz MM, Norval G, Perkins SL, Pike DA, Schoener TW, Templeton AR, Vazquez E, Walker A, Losos JB. Stroud JT, et al. Among authors: dufour cms. Am Nat. 2025 Nov;206(5):403-417. doi: 10.1086/737525. Epub 2025 Oct 13. Am Nat. 2025. PMID: 41172336
ERRγ impedes neuroendocrine prostate cancer development.
Li T, Dufour CR, Han L, Alfonso A, Farhat M, Beaumier A, Chen Q, Lu JJ, Giguère V. Li T, et al. Among authors: dufour cr. Genes Dev. 2025 Oct 29. doi: 10.1101/gad.353024.125. Online ahead of print. Genes Dev. 2025. PMID: 41162153
High-grade glioma, IDH- and H3-wildtype in young adults: a rare condition with a distinct epigenetic landscape.
Roux A, Tauziede-Espariat A, Simboli GA, Elia A, Moiraghi A, Hudelist B, Defrance G, Gehanno A, Dezamis E, Blauwblomme T, Dangouloff-Ros V, Boddaert N, Dufour C, Grill J, Muto J, Metais A, Saffroy R, Varlet P, Chretien F, Oppenheim C, Zanello M, Pallud J. Roux A, et al. Among authors: dufour c. J Neurooncol. 2025 Oct 16;176(1):22. doi: 10.1007/s11060-025-05246-z. J Neurooncol. 2025. PMID: 41099772
664 results